Recent News

Search by keywords:

522 News Items found

An Interview with Michael Glickman

Wednesday, October 1, 2008

Physician-scientist Michael S. Glickman specializes in the treatment and study of infectious diseases.

(Left to right) Medical oncologist Mark Robson, gynecologist Noah Kauff, medical oncologist Zsofia Stadler, and Clinical Genetics Service Chief Kenneth Offit are applying genetic insights to improve the care of cancer patients.

Genetic Information Becomes a Vital Part of Clinical Practice

Wednesday, October 1, 2008

At Memorial Sloan Kettering, as the genetics revolution continues to flourish, discoveries made in the laboratory are increasingly producing real-world benefits for cancer patients.

Scott Keeney Selected as a Howard Hughes Medical Institute Investigator

Wednesday, October 1, 2008

Scott N. Keeney, a member of the Molecular Biology Program within the Sloan Kettering Institute, was one of 56 researchers to be appointed a Howard Hughes Medical Institute (HHMI) investigator in 2008.

Thomas Kelly Named to Advisory Committee at National Institutes of Health

Thursday, May 1, 2008

Sloan Kettering Institute Director Thomas J. Kelly has been named a member of the Advisory Committee to the Director (ACD) at the National Institutes of Health.

Researchers Learn How Signaling Molecule Orchestrates Breast Cancer's Spread

Thursday, April 3, 2008

A study led by researchers at Memorial Sloan Kettering Cancer Center has uncovered how breast tumors use a particular type of molecule to promote metastasis - the spread of cancer cells.

Therapeutic Cloning Treats Parkinson's Disease in Mice

Sunday, March 23, 2008

Research led by investigators at Memorial Sloan Kettering Cancer Center has shown that therapeutic cloning, also known as somatic-cell nuclear transfer (SCNT), can be used to treat Parkinson's disease in mice.

Researchers Identify New Genetic Marker for Breast Cancer

Monday, March 3, 2008

An international group of investigators led by scientists at Memorial Sloan Kettering Cancer Center and the National Cancer Institute has identified a new genetic marker of risk for breast cancer. Women with this DNA variation are at a 1.4 times greater risk of developing breast cancer compared to those without the variation.

Novel Mechanism Found That May Boost Impaired Function of Leukemia Protein

Friday, February 29, 2008

A new study led by researchers at Memorial Sloan Kettering Cancer Center (MSKCC) reports on a novel mechanism that can enhance the function of a protein that is frequently impaired in patients with acute forms of leukemia.